Gene expression profile favoring phenotypic reversion: A clue for mechanism of tumor suppression by NF-IL6 3′UTR (Cell Research (2003) 13 (509-514) DOI:10.1038/sj.cr.7290195);Gene expression profile favoring phenotypic reversion: A clue for mechanism of tumor suppression by NF-IL6 3′UTR

Cell Research

Volumn 13, Issue 6, 2003, Pages 509-514

  Liu, Ding Gan ^a   Jiang, Qiu Hong ^a   Wei, Yun Yi ^a   Sun, Li ^a   Fu, Bei Bei ^a   Zhao, Fu Kun ^a   Zhou, Qiong ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

3 UTR; cDNA array; Hepatoma; NF IL6; Tumor suppression

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COMPLEMENTARY DNA;

3' UNTRANSLATED REGION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CARCINOGEN TESTING; CELL CLONE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHENOTYPE; TIME; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; CARCINOGENICITY TESTS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CLONE CELLS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 1842864081     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.23     Document Type: Erratum

References (25)

1. Liu DG, Noda M, Wang D, Chen ZZ, Li ZP, Ikawa Y. A cDNA clone with antioncogene activity. Sci China (Ser B)1991; 7:730-7 [in Chinese];
2. Sci.China (Ser B) 1992; 35:822-33 [in English].
3. Liu DG, Li ZP, Akira S, Kishimoto T. Overexpression of a reversion-related protein in the revertant RR cells. Sci China (Ser B) 1995; 35:372-8 [in Chinese];
4. Sci China (Ser C) 1996; 39:300-09 (in English).
5. Malumbress M, Perez de Castro I, Santos J, Fernandez Piqueras J, Pellicer A. Hypermethylation of the cell cycle inhibitor p14INK4b 3′untranslated region interferes with its transcription regulation in primary lymphomas. Oncogene 1999; 18:385-96.
6. Rastinejad F, Conboy MJ, Rando TA, Blau HM. Tumor suppression by RNA from the 3′untranslated region of alpha-tropomyosin. Cell 1993; 75:1107-17.
7. Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell'Orco, RT. The 3′untranslated region of prohibitin and cellular immortalization. Exp Cell Res 1996; 224:128-35.
8. Amara FM, Smith GM, Kuschak TI, Takeuchi TE, Wright JA. A cis-trans interaction at the 3′untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2 and TGF beta 3, Biochem Biophys Res Commun 1996; 228: 347-51.
9. Dong RC, Zhou RH, Lu FD, Tao WZ. Establishment of SMMC7721, a human hepatocarcinoma cell line, and observations on its biological characteristics. Journal of 2nd Military Medical University (Shanghai), 1980; 1:5-9 [in Chinese].
10. Xu XR, Huang J , Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J , Liu F, Huang QH, Cheng ZH,Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH , Gu WY, Huang WT, Zhao XT, Hu GL, Gu JR, Chen Z, Han ZG. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001; 8:15089-94.
11. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S , Matsui K, Takei Y, Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000; 404:42-9.
12. Druey KM, Blumer KJ, Kang VH, Kehr JH. Inhibition of G-protein- mediated MAP kinase activation by a new mammalian gene family. Nature 1996; 404:742-6.
13. Hedvat CV, Irving SG. The isolation and characterization of MINOR, a novel mitogen-inducible nuclear orphan receptor. Mol Endocrinol 1995; 9:1692-70.
14. Kocher O, Comella N, Tognazzi K, Brown EF. Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab Invest 1998; 78:117-25.
15. Sorom AJ, Nyberg SL, Gores GJ. Keratin, fas, and cryptogenic liver failure. Liver Transpl 2002; 8:1195-97.
16. Houldsworth J, Attardi G. Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. Proc Natl Acad Sci USA 1988; 85:377-81.
17. Tang Y, Katuri V, Dillner A, Mishra B, Deng CX, Mishra L. Disruption of transforming growth factor-β signaling in ELF β-spectrin-deficient mice. Science 2003; 299:574-7.
18. Huff T, Muller CS, Otto AM, Netzker R, Hannappel E. beta-Thymosins, small acidic peptides with multiple functions, Int. J. Biochem. Cell Biol 2001; 3:205-20.
19. Argraves WS, Suzuki S, Arai H, Thompson K, Pierschbacher MD, Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987; 105:1183-90.
20. Maass N, Hojo T, Zhang M, Sager R, Jonat W, Nagasaki K. Maspin-a novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncol 2001; 39:931-4.
21. Niimi S, Oshizawa T, Yamaguchi T, Harashima M, Seki T, Ariga T, Kawanishi T, Hayakawa T. Specific expression of annexin III in rat-small-hepatocytes, Biochem. Biophys. Res Commun 2003; 300:770-4.
22. Frosch BA, Berquin I, Emmert-Buck MR, Moin K, Sloane BF. Molecular regulation, membrane association and secretion of tumor cathepsin B. APMIS 1999; 107:28-37.
23. Strack S, Kini S, Ebner FF, Wadzinski BE, Colbran RJ. Differential cellular and subcellular localization of protein phosphatase 1 isoforms in brain. J Comp Neurol 1999; 413:373-84.
24. Davis S, Watson JC. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proc Natl Acad Sci USA1996; 93:508-13.
25. Denecke B, Meyerdierks A, Bottger EC. RGS1 is expressed in monocytes and acts as a GTPase-activating protein for G-protein-coupled chemoattractant receptors. J Biol Chem 1999; 274: 26860-8.